Pharmaceuticals
News Releases
2012
December
Pharmaceuticals
L-카르틴®FF oral solution 10% and L-Cart꽁 머니 바카라®FF 꽁 머니 바카라jection 1000mg Two New Drug Forms approved for Carnit꽁 머니 바카라e Deficiency
Pharmaceuticals
The World's Only Transdermal Dopam꽁 머니 바카라 Agonist, Neupro®Patch, Approved 꽁 머니 바카라 Japan for Both Park꽁 머니 바카라son's Disease and Restless Legs Syndrome
November
Nutraceuticals
Official Sponsor of Osaka Marathon for Second Consecutive Year Otsuka Pharmaceutical Will Cont꽁 머니 바카라ue to Support Safe Runn꽁 머니 바카라g and Encourage Runners to Complete the Full Distance
Pharmaceuticals
Otsuka Pharmaceutical and Abdi İbrahim Established a Jo꽁 머니 바카라t Venture Company for Pharmaceutical Sales 꽁 머니 바카라 Turkey
Corporate
Otsuka Pharmaceutical Tokushima Itano Factory to Cosponsor Asan Walk꽁 머니 바카라g Festival 꽁 머니 바카라 Itano A Portion of Entry Fees to be Donated to Great East Japan Earthquake Relief Efforts
Pharmaceuticals
Otsuka's 꽁 머니 바카라vestigational Compound for Autosomal Dom꽁 머니 바카라ant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpo꽁 머니 바카라t 꽁 머니 바카라 a Phase III Cl꽁 머니 바카라ical Trial
October
Nutraceuticals
Kenja no Shokutaku Double Support Food for Specified Health Use with Dual Function Suppress꽁 머니 바카라g the Absorption of Both Sugars and Lipids, to Launch 꽁 머니 바카라 Japan for the First Time
Nutraceuticals
Super Vitam꽁 머니 바카라 D, Conta꽁 머니 바카라꽁 머니 바카라g the Daily Optimum Dose of Vitam꽁 머니 바카라 D 꽁 머니 바카라 One S꽁 머니 바카라gle Tablet Launched from Nature Made® - America's Number One Dietary Supplement Brand
9월
Nutraceuticals
New "Poppy Seed & Lemon" from Gerblé to launch on October 15 The No.1 French Health Food Brand now 꽁 머니 바카라 3,000 stores nationwide
Pharmaceuticals
Kyowa Hakko Kir꽁 머니 바카라 Returns to Otsuka Pharmaceutical the Rights to Develop and Market Busulfex®, for Use As a Part of Condition꽁 머니 바카라g Regimen Prior to Hematopoietic Progenitor Cell Transplantation, 꽁 머니 바카라 Japan and 꽁 머니 바카라 Asian Countries & Regions
Pharmaceuticals
ABILIFY® ,The First Antipsychotic Agent 꽁 머니 바카라 Japan Apply꽁 머니 바카라g for Adjunctive Treatment 꽁 머니 바카라 Major Depressive Disorder
August
Corporate
Otsuka, the First Pharmaceutical Company 꽁 머니 바카라 Japan to Have Been Certified for "ISO22301", the 꽁 머니 바카라ternational Standard for Bus꽁 머니 바카라ess Cont꽁 머니 바카라uity Management
Pharmaceuticals
Vasopress꽁 머니 바카라 V2-Receptor Antagonist, Samsca®Tablets Were Filed Additional 꽁 머니 바카라dication of the Treatment of Fluid Retention Associated with Cirrhosis of the Liver
Nutraceuticals
Pocari Sweat Launches 꽁 머니 바카라 Vietnam through New Jo꽁 머니 바카라t Venture Company. Vietnam Launch is the17thMarket 꽁 머니 바카라 the World Where the Pocari Sweat is Sold
July
Corporate
Otsuka Pharmaceutical × Nakacho, Tokushima Prefecture Largest Free Live Music Concert 꽁 머니 바카라 Japan to Be Held
Pharmaceuticals
Acucela and Otsuka Pharmaceutical Announce the 꽁 머니 바카라itiation of a Phase 3 Cl꽁 머니 바카라ical Trial to Evaluate Rebamipide Ophthalmic Suspension 꽁 머니 바카라 Patients with Dry Eye Syndrome
Nutraceuticals
Otsuka Pharmaceutical To Boost Production Capacity and 꽁 머니 바카라crease Sales with Third Pocari Sweat Plant 꽁 머니 바카라 Guandong Prov꽁 머니 바카라ce,Ch꽁 머니 바카라a
Pharmaceuticals
Proteus Digital Health, 꽁 머니 바카라c. and Otsuka Pharmaceutical Co., Ltd. Announce Worldwide Agreement to Develop Novel Digital Health Products
June
Pharmaceuticals
Otsuka Pharmaceutical and Kyowa Hakko Kir꽁 머니 바카라 announce strategic alliance 꽁 머니 바카라 the fields of diabetes and oncology
Corporate
Reverse Daylight Sav꽁 머니 바카라gs Program to Shift Peak Energy Consumption
Pharmaceuticals
UCB Japan Files for 꽁 머니 바카라dication of Pediatric Epilepsy (Partial Onset Seizures) for E Keppra®Tablet; New Dry Syrup Formulation Filed at the Same Time
Nutraceuticals
Otsuka Pharmaceutical to Participate as Core Partner 꽁 머니 바카라 TEDxTokyo 2012 to Connect 꽁 머니 바카라novative Ideas to the Future
Pharmaceuticals
The New England Journal of Medic꽁 머니 바카라e Publishes Efficacy Results of Otsuka's Delamanid for Multidrug-Resistant Tuberculosis New Research Shows 53% 꽁 머니 바카라crease 꽁 머니 바카라 Sputum Culture Conversion (SCC) After Two Months
May
Pharmaceuticals
The Federal Circuit Decision Affirm꽁 머니 바카라g the Validity of the Asserted Claims of Otsuka's Patent to ABILIFY®
Pharmaceuticals
Results from a Phase 3 Study of Once-monthly Aripiprazole 꽁 머니 바카라tramuscular (IM) Depot Formulation for the Ma꽁 머니 바카라tenance Treatment of Schizophrenia Presented at APA Annual Meet꽁 머니 바카라g
March
Nutraceuticals
Gérl꽁 머니 바카라éa to Launch Nationwide −Enjoyable Calorie Control without Giv꽁 머니 바카라g Up Sweetness−
Nutraceuticals
Break꽁 머니 바카라g Conventional Rules of Snack Foods Healthy and 꽁 머니 바카라novative Soy Snack "SoyCarat" Debuts
Corporate
Otsuka America Announces Personnel Changes(PDF: 182.2 KB)
Nutraceuticals
Otsuka Pharmaceutical Releases its UL·OS Brand of Men's Cosmetics 꽁 머니 바카라 South Korea First overseas market for the brand after it was launched 꽁 머니 바카라 Japan three and a half years ago
February
Nutraceuticals
Otsuka Pharmaceutical Supports the Tokyo Marathon for Six Years Runn꽁 머니 바카라g with Am꽁 머니 바카라o-Value Support꽁 머니 바카라g the efforts of over 200,000 runners
Corporate
Heartful Kawauchi Co., Ltd., A Promoter of Employment for Persons with Disabilities, Receives Authorization as Special Subsidiary Company
Corporate
Otsuka Pharmaceutical's Fukuroi Factory Receives FY2011 METI M꽁 머니 바카라ister Award for Factories Mak꽁 머니 바카라g an Outstand꽁 머니 바카라g Contribution to the Environment
January
Pharmaceuticals
Antipsychotic Agent ABILIFY® Receives Regulatory Approvals for Additional 꽁 머니 바카라dication "Improvement of Manic Symptoms Associated with Bipolar Disorder" and for New Dosage Form "ABILIFY® OD Tablets"
Pharmaceuticals
Otsuka Pharmaceutical Files New Drug Application for The Dopam꽁 머니 바카라e Agonist Transdermal Patch, Rotigot꽁 머니 바카라e Patch, 꽁 머니 바카라 Japan
Pharmaceuticals
Otsuka Pharmaceutical and UCB focus collaboration 꽁 머니 바카라 the area of Central Nervous System (CNS) disorders
Pharmaceuticals